Remote Behavioral Intervention Effective in Lowering Blood Pressure Variability

A new study reveals that remotely delivered behavioral interventions can effectively reduce systolic blood pressure variability, fostering better blood pressure control and reducing cardiovascular risks.
A recent study published in Scientific Reports has demonstrated that remotely delivered behavioral interventions can significantly reduce the variability of systolic blood pressure, known as the coefficient of variation (BPCoV). This research, conducted by Dr. Eyal Shemesh and colleagues from the Icahn School of Medicine at Mount Sinai in New York City, offers promising insights into managing blood pressure fluctuations through remote patient engagement.
The study involved a single-arm prospective proof-of-concept trial with patients exhibiting high blood pressure variability (BPCoV over 10%), identified through electronic health record reviews. Participants were provided with a blood pressure monitor and received behavioral interventions remotely over a three-month period. Out of 551 screened patients, 107 demonstrated high BPCoV, and 25 opted to participate in the intervention.
Results showed that the average BPCoV decreased from 12.96 in the six months prior to enrollment to 7.02 during the intervention, indicating a substantial reduction in blood pressure variability. Improvements were also noted across other variability measures, with data remaining consistent across different measurement methods, including clinic and home readings.
Dr. Shemesh emphasized the importance of monitoring blood pressure over time, rather than solely focusing on single-visit readings. The study highlights that remote engagement can effectively help patients stabilize their blood pressure, which is crucial for reducing cardiovascular risks associated with blood pressure fluctuations.
This innovative approach demonstrates that patients can be empowered to participate in their health management remotely, potentially transforming hypertension care. For more details, the full study can be accessed via source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
U.S. Government Considers Linking Tylenol to Autism Risks
The Trump administration is considering linking acetaminophen, the active ingredient in Tylenol, to autism risk and advising pregnant women to avoid its use unless necessary. This move reflects ongoing debates about medication safety during pregnancy.
Rebuilding the Global Health System in the Wake of US Aid Reductions: A Path Forward
Amid US aid reductions, opportunities for global health system reform emerge. Strengthening primary care, promoting health equity, and fostering international partnerships can build a more resilient future for global health.
Innovative Tissue-Integrated Bionic Knee Restores Natural Leg Movement
MIT has unveiled a pioneering tissue-integrated bionic knee that offers enhanced stability, control, and natural movement for above-the-knee amputees, revolutionizing prosthetic technology and embodiment.
Gummy Shark: A Safe and Sustainable Protein Alternative for Children with Fish Allergies
New research indicates that gummy shark may be a safe and sustainable dietary option for children with fish allergies, offering hope for better nutrition and allergy management.